PCSK9LDLR/STAT-3/ROR-γtTh17

Miao Yu1, Wenjing Tang1, Wei Liang1

  • 1Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China; Hubei Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China; Hubei Provincial Engineering Research Center of Immunological Diagnosis and Therapy for Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.

PubMed
概括

在实验性自身免疫性心肌炎中,蛋白转化酶 (subtilisin kexin type 9) (PCSK9) 抑制减少了心脏炎症. 阻断PCSK9降低了Th17细胞分化,这表明PCSK9是心肌炎的治疗点.